Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             187 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice Schneider-Ohrum, Kirsten
 2011
 29 Supplement 4 p. 9081-9092
12 p.
 artikel
2 A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection Lima, Danielle Malta
 2011
 29 Supplement 4 p. 831-838
8 p.
 artikel
3 A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness Gunther, V.J.
 2011
 29 Supplement 4 p. 3895-3904
10 p.
 artikel
4 A live attenuated strain of Yersinia pestis KIM as a vaccine against plague Sun, Wei
 2011
 29 Supplement 4 p. 2986-2998
13 p.
 artikel
5 A method for estimating vaccine-preventable pediatric influenza pneumonia hospitalizations in developing countries: Thailand as a case study Dawood, Fatimah S.
 2011
 29 Supplement 4 p. 4416-4421
6 p.
 artikel
6 A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness Langley, J.M.
 2011
 29 Supplement 4 p. 1921-1928
8 p.
 artikel
7 An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice Hu, Kai
 2011
 29 Supplement 4 p. 1455-1462
8 p.
 artikel
8 An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults Talaat, Kawsar R.
 2011
 29 Supplement 4 p. 3144-3148
5 p.
 artikel
9 A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: The recombinant swinepox virus expressing M-like protein Lin, Hui-xing
 2011
 29 Supplement 4 p. 7027-7034
8 p.
 artikel
10 Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization Safari, Dodi
 2011
 29 Supplement 4 p. 6498-6504
7 p.
 artikel
11 Antibody persistence at 18–20months of age and safety and immunogenicity of a booster dose of a combined DTaP–IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China Li, Rong Cheng
 2011
 29 Supplement 4 p. 9337-9344
8 p.
 artikel
12 Antibody responses after intravaginal immunisation with trimeric HIV-1CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation Cranage, Martin P.
 2011
 29 Supplement 4 p. 1421-1430
10 p.
 artikel
13 Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children Meier, Sara
 2011
 29 Supplement 4 p. 3548-3557
10 p.
 artikel
14 Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A Matyas, Gary R.
 2011
 29 Supplement 4 p. 5137-5144
8 p.
 artikel
15 A Phase I safety study of plasmid DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients Staff, Caroline
 2011
 29 Supplement 4 p. 6817-6822
6 p.
 artikel
16 A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years Tennis, Patricia
 2011
 29 Supplement 4 p. 4947-4952
6 p.
 artikel
17 A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older Forrest, Bruce D.
 2011
 29 Supplement 4 p. 3633-3639
7 p.
 artikel
18 A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults Block, Stan L.
 2011
 29 Supplement 4 p. 9391-9397
7 p.
 artikel
19 A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants Bernstein, David I.
 2011
 29 Supplement 4 p. 7042-7048
7 p.
 artikel
20 A systematic review of intradermal influenza vaccines Young, Flora
 2011
 29 Supplement 4 p. 8788-8801
14 p.
 artikel
21 Atraumatic osteonecrosis of the humeral head after influenza A-(H1N1) v-2009 vaccination Kuether, G.
 2011
 29 Supplement 4 p. 6830-6833
4 p.
 artikel
22 Bioprocess optimization for cell culture based influenza vaccine production Aggarwal, Kunal
 2011
 29 Supplement 4 p. 3320-3328
9 p.
 artikel
23 Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania Bakari, Muhammad
 2011
 29 Supplement 4 p. 8417-8428
12 p.
 artikel
24 Changing epidemiology of hepatitis A infection in Izmir, Turkey Kurugol, Zafer
 2011
 29 Supplement 4 p. 6259-6261
3 p.
 artikel
25 Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults Silva, Maria Luiza
 2011
 29 Supplement 4 p. 583-592
10 p.
 artikel
26 Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine Adler-Moore, Jill
 2011
 29 Supplement 4 p. 4460-4468
9 p.
 artikel
27 Comparative study of the immune effect of an Edwardsiella tarda antigen in two forms: Subunit vaccine vs DNA vaccine Sun, Yun
 2011
 29 Supplement 4 p. 2051-2057
7 p.
 artikel
28 Comparing live attenuated and inactivated hepatitis A vaccines: An immunogenicity study after one single dose Zheng, Hui
 2011
 29 Supplement 4 p. 9098-9103
6 p.
 artikel
29 Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus Zhang, Deqing
 2011
 29 Supplement 4 p. 629-635
7 p.
 artikel
30 Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and Neisserial heparin binding antigen Vu, David M.
 2011
 29 Supplement 4 p. 1968-1973
6 p.
 artikel
31 Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective Smith, Emily R.
 2011
 29 Supplement 4 p. 6704-6711
8 p.
 artikel
32 Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities den Elzen, Wendy P.J.
 2011
 29 Supplement 4 p. 4869-4874
6 p.
 artikel
33 Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets Layton, R. Colby
 2011
 29 Supplement 4 p. 6242-6251
10 p.
 artikel
34 Dendritic cells can effectively be pulsed by HBVsvp and induce specific immune reactions in mice Farag, Mohamed M.S.
 2010
 29 Supplement 4 p. 200-206
7 p.
 artikel
35 Detection of platelet-binding anti-measles and anti-rubella virus IgG antibodies in infants with vaccine-induced thrombocytopenic purpura Okazaki, Naho
 2011
 29 Supplement 4 p. 4878-4880
3 p.
 artikel
36 Development and characterization of chitosan coated poly-(ε-caprolactone) nanoparticulate system for effective immunization against influenza Gupta, Nand Kishore
 2011
 29 Supplement 4 p. 9026-9037
12 p.
 artikel
37 Development of an inactivated candidate vaccine against Chandipura virus (Rhabdoviridae: Vesiculovirus) Jadi, R.S.
 2011
 29 Supplement 4 p. 4613-4617
5 p.
 artikel
38 Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever Osorio, Jorge E.
 2011
 29 Supplement 4 p. 7251-7260
10 p.
 artikel
39 Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children Hendrikx, Lotte H.
 2011
 29 Supplement 4 p. 6874-6880
7 p.
 artikel
40 Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination Clarke, Michelle F.
 2011
 29 Supplement 4 p. 4663-4667
5 p.
 artikel
41 Divergence of immunologic and protective responses of different BCG strains in a murine model Kozak, R.
 2011
 29 Supplement 4 p. 1519-1526
8 p.
 artikel
42 Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1×, 2×, or 4×) in healthy subjects aged 70 years or older Lode, H.
 2011
 29 Supplement 4 p. 4940-4946
7 p.
 artikel
43 Early immune responses in Atlantic salmon (Salmo salar L.) after immunization with PLGA nanoparticles loaded with a model antigen and β-glucan Fredriksen, B.N.
 2011
 29 Supplement 4 p. 8338-8349
12 p.
 artikel
44 Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children Ploin, Dominique
 2011
 29 Supplement 4 p. 8438-8442
5 p.
 artikel
45 Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy Boccalini, Sara
 2011
 29 Supplement 4 p. 9521-9528
8 p.
 artikel
46 Editorial Board 2011
 29 Supplement 4 p. CO2-
1 p.
 artikel
47 Editorial Board 2011
 29 Supplement 4 p. CO2-
1 p.
 artikel
48 Editorial Board 2011
 29 Supplement 4 p. CO2-
1 p.
 artikel
49 Editorial Board 2011
 29 Supplement 4 p. CO2-
1 p.
 artikel
50 Editorial Board 2011
 29 Supplement 4 p. CO2-
1 p.
 artikel
51 Editorial Board 2011
 29 Supplement 4 p. CO2-
1 p.
 artikel
52 Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural Communities Zhang, Yong
 2011
 29 Supplement 4 p. 3905-3908
4 p.
 artikel
53 Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine Miller, Elizabeth
 2011
 29 Supplement 4 p. 9127-9131
5 p.
 artikel
54 Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7–59 months. A matched case-control study Domínguez, Angela
 2011
 29 Supplement 4 p. 9020-9025
6 p.
 artikel
55 Effect of GonaCon™ vaccine on black-tailed prairie dogs: Immune response and health effects Yoder, Christi A.
 2010
 29 Supplement 4 p. 233-239
7 p.
 artikel
56 Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal Shuaibu, M.N.
 2011
 29 Supplement 4 p. 3239-3247
9 p.
 artikel
57 Effect of oral administration of ginseng stem-and-leaf saponins (GSLS) on the immune responses to Newcastle disease vaccine in chickens Zhai, Lijuan
 2011
 29 Supplement 4 p. 5007-5014
8 p.
 artikel
58 Effect of vaccination of pigs against experimental infection with high and low virulence Mycoplasma hyopneumoniae strains Villarreal, I.
 2011
 29 Supplement 4 p. 1731-1735
5 p.
 artikel
59 Enhanced immune sera and vaccine: Safe approach to treat scorpion envenoming Lila, Boussag-Abib
 2011
 29 Supplement 4 p. 8951-8959
9 p.
 artikel
60 Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: A randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age Matsuda, F.
 2011
 29 Supplement 4 p. 1855-1858
4 p.
 artikel
61 Evaluation of Cryptococcus neoformans galactoxylomannan–protein conjugate as vaccine candidate against murine cryptococcosis Chow, Siu-Kei
 2011
 29 Supplement 4 p. 1891-1898
8 p.
 artikel
62 Evaluation of growth based rapid microbiological methods for sterility testing of vaccines and other biological products Parveen, Seema
 2011
 29 Supplement 4 p. 8012-8023
12 p.
 artikel
63 Evaluation of hha and hha sepB mutant strains of Escherichia coli O157:H7 as bacterins for reducing E. coli O157:H7 shedding in cattle Sharma, Vijay K.
 2011
 29 Supplement 4 p. 5078-5086
9 p.
 artikel
64 Evaluation of recombinant fowlpox virus expressing infectious bronchitis virus S1 gene and chicken interferon-γ gene for immune protection against heterologous strains Shi, Xing-Ming
 2011
 29 Supplement 4 p. 1576-1582
7 p.
 artikel
65 Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka Dias, Sajani
 2011
 29 Supplement 4 p. 7491-7504
14 p.
 artikel
66 Evaluation of the reliability, validity and practicality of 3 measures of acute pain in infants undergoing immunization injections Taddio, Anna
 2011
 29 Supplement 4 p. 1390-1394
5 p.
 artikel
67 From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine Guy, Bruno
 2011
 29 Supplement 4 p. 7229-7241
13 p.
 artikel
68 α-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice Li, Kai
 2011
 29 Supplement 4 p. 7711-7717
7 p.
 artikel
69 Genetic polymorphisms in host antiviral genes: Associations with humoral and cellular immunity to measles vaccine Haralambieva, Iana H.
 2011
 29 Supplement 4 p. 8988-8997
10 p.
 artikel
70 Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses Mantel, N.
 2011
 29 Supplement 4 p. 6629-6635
7 p.
 artikel
71 Guillain–Barré Syndrome in India: Population-based validation of the Brighton criteria Mateen, Farrah J.
 2011
 29 Supplement 4 p. 9697-9701
5 p.
 artikel
72 Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras Jacups, Susan P.
 2011
 29 Supplement 4 p. 3083-3088
6 p.
 artikel
73 Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice Wang, Saifeng
 2011
 29 Supplement 4 p. 6342-6351
10 p.
 artikel
74 HelicoVax: Epitope-based therapeutic Helicobacter pylori vaccination in a mouse model Moss, Steven F.
 2011
 29 Supplement 4 p. 2085-2091
7 p.
 artikel
75 Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice Naarding, Marloes A.
 2011
 29 Supplement 4 p. 2910-2917
8 p.
 artikel
76 HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines Landuzzi, Lorena
 2011
 29 Supplement 4 p. 4690-4697
8 p.
 artikel
77 High burden of tick-borne encephalitis in Slovenia—Challenge for vaccination policy Grgič-Vitek, Marta
 2011
 29 Supplement 4 p. 5178-5183
6 p.
 artikel
78 Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus Devlin, Joanne M.
 2011
 29 Supplement 4 p. 5699-5704
6 p.
 artikel
79 Horizontal transmission of a human rotavirus vaccine strain—A randomized, placebo-controlled study in twins Rivera, Luis
 2011
 29 Supplement 4 p. 9508-9513
6 p.
 artikel
80 Hospital initiation of a vaccinal schedule improves the long-term vaccinal coverage of ex-preterm children Denizot, S.
 2011
 29 Supplement 4 p. 382-386
5 p.
 artikel
81 Humoral immune response of a pneumococcal conjugate vaccine: Capsular polysaccharide serotype 14—Lysine modified PspA Santamaria, Raquel
 2011
 29 Supplement 4 p. 8689-8695
7 p.
 artikel
82 Identification of major antigenic peptide of filarial glutathione-S-transferase Yadav, Marshleen
 2011
 29 Supplement 4 p. 1297-1303
7 p.
 artikel
83 Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins Hendrikx, Lotte H.
 2011
 29 Supplement 4 p. 1431-1437
7 p.
 artikel
84 Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model Julander, Justin G.
 2011
 29 Supplement 4 p. 6008-6016
9 p.
 artikel
85 Immune response of Atlantic salmon to recombinant flagellin Hynes, Natasha A.
 2011
 29 Supplement 4 p. 7678-7687
10 p.
 artikel
86 Immune responses induced by heat killed Saccharomyces cerevisiae: A vaccine against fungal infection Liu, Min
 2011
 29 Supplement 4 p. 1745-1753
9 p.
 artikel
87 Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen Franceschi, Valentina
 2011
 29 Supplement 4 p. 3074-3082
9 p.
 artikel
88 Immunization with the RTS,S/AS malaria vaccine induces IFN-γ +CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge Schwenk, Robert
 2011
 29 Supplement 4 p. 8847-8854
8 p.
 artikel
89 Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP–IPV) compared to separate administration of standalone DTaP and IPV vaccines: A randomized, controlled study in infants in the Republic of Korea Lee, Soo Young
 2011
 29 Supplement 4 p. 1551-1557
7 p.
 artikel
90 Immunogenicity and safety of a combined diphtheria, tetanus, 5-component acellular pertussis, inactivated poliomyelitis, Haemophilus type b conjugate vaccine when administered concurrently with a pneumococcal conjugate vaccine: A randomized, open-label, phase 3 study Bernstein, Henry H.
 2011
 29 Supplement 4 p. 2212-2221
10 p.
 artikel
91 Immunogenicity and safety of a Haemophilus influenzae B (Hib)–hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants Lee, Andrew W.
 2011
 29 Supplement 4 p. 7942-7948
7 p.
 artikel
92 Immunogenicity and safety of a measles–mumps–rubella–varicella vaccine following a 4-week or a 12-month interval between two doses Rümke, H.C.
 2011
 29 Supplement 4 p. 3842-3849
8 p.
 artikel
93 Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China Li, Rong Cheng
 2011
 29 Supplement 4 p. 1913-1920
8 p.
 artikel
94 Immunogenicity and safety of a single intramuscular dose of a diphtheria–tetanus toxoid (Td) vaccine (GC1107) in Korean adults Lee, SeungHwan
 2011
 29 Supplement 4 p. 7638-7643
6 p.
 artikel
95 Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants Grimprel, E.
 2011
 29 Supplement 4 p. 9675-9683
9 p.
 artikel
96 Immunogenicity and safety of CRM197 conjugated 9-valent pneumococcal and meningococcal C combination vaccine in healthy infants Mallet, Eric
 2011
 29 Supplement 4 p. 5812-5819
8 p.
 artikel
97 Immunogenicity and safety of fully liquid DTaP5-IPV-Hib compared with DTaP3-IPV/Hib when both coadministered with a heptavalent pneumococcal conjugate vaccine (PCV7) at 2, 3, 4, and 12 to 18 months of age: A phase III, single-blind, randomised, controlled, multicentre study Grimprel, Emmanuel
 2011
 29 Supplement 4 p. 7370-7378
9 p.
 artikel
98 Immunogenicity and safety of heptavalent conjugate vaccine against Streptococcus pneumoniae in pre-term Polish infants Szynczewska, Ewa
 2011
 29 Supplement 4 p. 7107-7113
7 p.
 artikel
99 Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys Koeberling, Oliver
 2011
 29 Supplement 4 p. 4728-4734
7 p.
 artikel
100 Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein Iankov, Ianko D.
 2011
 29 Supplement 4 p. 1710-1720
11 p.
 artikel
101 Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients Torii, Yuka
 2011
 29 Supplement 4 p. 4187-4189
3 p.
 artikel
102 Immunoglobulin deficiency in children with Hib vaccine failure Ladhani, Shamez
 2011
 29 Supplement 4 p. 9137-9140
4 p.
 artikel
103 Impact of birth weight at term on rates of emergency room visits and hospital admissions following vaccination at 2 months of age Wilson, Kumanan
 2011
 29 Supplement 4 p. 8267-8274
8 p.
 artikel
104 Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age Hendrikx, Lotte H.
 2011
 29 Supplement 4 p. 5725-5730
6 p.
 artikel
105 Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy Pozza, Francesca
 2011
 29 Supplement 4 p. 9480-9487
8 p.
 artikel
106 Implementation of mandatory immunisation of healthcare workers: Observations from New South Wales, Australia Helms, Charles
 2011
 29 Supplement 4 p. 2895-2901
7 p.
 artikel
107 Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine Neimert-Andersson, Theresa
 2011
 29 Supplement 4 p. 8965-8973
9 p.
 artikel
108 Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease Moraes, Theo J.
 2011
 29 Supplement 4 p. 6301-6312
12 p.
 artikel
109 Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice Wu, Juan
 2011
 29 Supplement 4 p. 7624-7630
7 p.
 artikel
110 Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response Moraes, Mauro Pires
 2011
 29 Supplement 4 p. 9431-9440
10 p.
 artikel
111 Induction of TLR4-dependent CD8+ T cell immunity by murine β-defensin2 fusion protein vaccines Park, H.J.
 2011
 29 Supplement 4 p. 3476-3482
7 p.
 artikel
112 Innate immunity in DNA vaccine with Toxoplasma gondii-heat shock protein 70 gene that induces DC activation and Th1 polarization Makino, Masayuki
 2011
 29 Supplement 4 p. 1899-1905
7 p.
 artikel
113 “In vitro systems to characterize the immune response to HIV-1 and HIV-1 vaccine candidates”, NIAID Workshop Report, Bethesda, August 4, 2010 Malaspina, Angela
 2011
 29 Supplement 4 p. 4647-4653
7 p.
 artikel
114 Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium) Lefevere, Eva
 2011
 29 Supplement 4 p. 8390-8396
7 p.
 artikel
115 Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines Capeding, Rosario Z.
 2011
 29 Supplement 4 p. 3863-3872
10 p.
 artikel
116 Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets Baras, Benoît
 2011
 29 Supplement 4 p. 2092-2099
8 p.
 artikel
117 Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals Anthony, D.D.
 2011
 29 Supplement 4 p. 3558-3563
6 p.
 artikel
118 Malaria vaccine candidate: Design of a multivalent subunit α-helical coiled coil poly-epitope Olugbile, Sope
 2011
 29 Supplement 4 p. 7090-7099
10 p.
 artikel
119 Maternal antibodies to rotavirus: Could they interfere with live rotavirus vaccines in developing countries? Chan, J.
 2011
 29 Supplement 4 p. 1242-1247
6 p.
 artikel
120 MMR vaccine effectiveness in an outbreak that involved day-care and primary schools Barrabeig, Irene
 2011
 29 Supplement 4 p. 8024-8031
8 p.
 artikel
121 Mother–infant vaccination with pneumococcal polysaccharide vaccine: Persistence of maternal antibodies and responses of infants to vaccination Holmlund, Emma
 2011
 29 Supplement 4 p. 4565-4575
11 p.
 artikel
122 Neuropathology of vaccination in infants and children Rorke-Adams, Lucy B.
 2011
 29 Supplement 4 p. 8754-8759
6 p.
 artikel
123 Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis Blazevic, Vesna
 2011
 29 Supplement 4 p. 8126-8133
8 p.
 artikel
124 Novel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice Gao, Xiang
 2011
 29 Supplement 4 p. 6656-6663
8 p.
 artikel
125 “Once I begin to participate, people will run away from me”: Understanding stigma as a barrier to HIV vaccine research participation in Kenya Nyblade, Laura
 2011
 29 Supplement 4 p. 8924-8928
5 p.
 artikel
126 Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: Immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination Lagler, Heimo
 2011
 29 Supplement 4 p. 6888-6893
6 p.
 artikel
127 Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children Glanz, Jason M.
 2011
 29 Supplement 4 p. 994-999
6 p.
 artikel
128 Patterns of emergency room visits, admissions and death following recommended pediatric vaccinations—A population based study of 969,519 vaccination events Wilson, Kumanan
 2011
 29 Supplement 4 p. 3746-3752
7 p.
 artikel
129 Persistence of antibodies in 4–8 year old Austrian children after vaccination with hexavalent DTaP–HBV–IPV/Hib and MMR vaccines Paulke-Korinek, Maria
 2011
 29 Supplement 4 p. 5130-5136
7 p.
 artikel
130 Polyfunctional analysis of Gag and Nef specific CD8+ T-cell responses in HIV-1 infected Indian individuals Mendiratta, Sanjay
 2011
 29 Supplement 4 p. 1150-1158
9 p.
 artikel
131 Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model Skinner, Julie M.
 2011
 29 Supplement 4 p. 8870-8876
7 p.
 artikel
132 Predictors of acceptance of H1N1 influenza vaccination by FDNY firefighters and EMS workers Glaser, Michelle S.
 2011
 29 Supplement 4 p. 5675-5680
6 p.
 artikel
133 Predictors of HPV vaccine uptake among women aged 19–26: Importance of a physician's recommendation Rosenthal, S.L.
 2011
 29 Supplement 4 p. 890-895
6 p.
 artikel
134 Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule Wiertsema, Selma P.
 2011
 29 Supplement 4 p. 5163-5170
8 p.
 artikel
135 Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination Zhu, Chang-Lin
 2011
 29 Supplement 4 p. 7835-7841
7 p.
 artikel
136 Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States Wang, Xin
 2011
 29 Supplement 4 p. 4739-4744
6 p.
 artikel
137 Prevenar experience Arguedas, Adriano
 2011
 29 Supplement 4 p. C26-C34
nvt p.
 artikel
138 Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling Partidos, Charalambos D.
 2011
 29 Supplement 4 p. 3067-3073
7 p.
 artikel
139 Prospective pertussis surveillance in Switzerland, 1991–2006 Wymann, Monica N.
 2011
 29 Supplement 4 p. 2058-2065
8 p.
 artikel
140 Protection provided by a recombinant ALVAC®-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain Minke, J.M.
 2011
 29 Supplement 4 p. 4608-4612
5 p.
 artikel
141 Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: Findings from a systematic review of the published literature, 1999–2009 Rainey, Jeanette J.
 2011
 29 Supplement 4 p. 8215-8221
7 p.
 artikel
142 RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection Monney, Thierry
 2011
 29 Supplement 4 p. 6967-6975
9 p.
 artikel
143 Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4–6 years old Quinn, Patrick
 2011
 29 Supplement 4 p. 4230-4237
8 p.
 artikel
144 Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects Yanagisawa, Naoki
 2011
 29 Supplement 4 p. 5694-5698
5 p.
 artikel
145 Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines Ohtake, Satoshi
 2011
 29 Supplement 4 p. 2761-2771
11 p.
 artikel
146 Rotavirus shedding in premature infants following first immunization Smith, Candice K.
 2011
 29 Supplement 4 p. 8141-8146
6 p.
 artikel
147 Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02) García, Felipe
 2011
 29 Supplement 4 p. 8309-8316
8 p.
 artikel
148 Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: A phase III open-label single-arm study Loebermann, M.
 2011
 29 Supplement 4 p. 1228-1234
7 p.
 artikel
149 Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age Diaz-Mitoma, Francisco
 2011
 29 Supplement 4 p. 1324-1331
8 p.
 artikel
150 Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance Kurz, Xavier
 2011
 29 Supplement 4 p. 4378-4387
10 p.
 artikel
151 Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer Halasa, Natasha
 2011
 29 Supplement 4 p. 4110-4115
6 p.
 artikel
152 Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in the spike 2 domain and the nucleocapsid protein of feline infectious peritonitis virus Satoh, Ryoichi
 2011
 29 Supplement 4 p. 1791-1800
10 p.
 artikel
153 Seasonal influenza vaccination in adults: Practice and attitudes about collaborative delivery with community vaccinators Hurley, Laura P.
 2011
 29 Supplement 4 p. 8649-8655
7 p.
 artikel
154 Seroepidemiological study of pandemic influenza H1N1 following the 2009–2010 wave in Greece Maltezou, Helena C.
 2011
 29 Supplement 4 p. 6664-6669
6 p.
 artikel
155 Seroprevalence of IgG antibodies against 13 vaccine Streptococcus pneumoniae serotypes in the Netherlands Elberse, K.E.M.
 2011
 29 Supplement 4 p. 1029-1035
7 p.
 artikel
156 Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000–2007 Menezes, Ana Paula de O.
 2011
 29 Supplement 4 p. 1139-1144
6 p.
 artikel
157 Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009–March 2010 Folkenberg, Maja
 2011
 29 Supplement 4 p. 1180-1184
5 p.
 artikel
158 Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods Patois, E.
 2011
 29 Supplement 4 p. 7404-7413
10 p.
 artikel
159 Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: Lessons learned by PAHO's ProVac Initiative Jauregui, Barbara
 2011
 29 Supplement 4 p. 1099-1106
8 p.
 artikel
160 Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory Demberg, Thorsten
 2011
 29 Supplement 4 p. 6017-6028
12 p.
 artikel
161 Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice Amuguni, J. Hellen
 2011
 29 Supplement 4 p. 4778-4784
7 p.
 artikel
162 Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine Zhang, Wei
 2011
 29 Supplement 4 p. 6276-6282
7 p.
 artikel
163 Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs Donofrio, Gaetano
 2011
 29 Supplement 4 p. 867-872
6 p.
 artikel
164 Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo Powell, Thomas J.
 2011
 29 Supplement 4 p. 558-569
12 p.
 artikel
165 Text message reminders to promote human papillomavirus vaccination Kharbanda, Elyse Olshen
 2011
 29 Supplement 4 p. 2537-2541
5 p.
 artikel
166 The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab Arad, U.
 2011
 29 Supplement 4 p. 1643-1648
6 p.
 artikel
167 The current perspective on tick-borne encephalitis awareness and prevention in six Central and Eastern European countries: Report from a meeting of experts convened to discuss TBE in their region Kollaritsch, Herwig
 2011
 29 Supplement 4 p. 4556-4564
9 p.
 artikel
168 The current status of invasive pneumococcal disease in Poland Skoczyńska, Anna
 2011
 29 Supplement 4 p. 2199-2205
7 p.
 artikel
169 The effects of vaccine characteristics on adult women's attitudes about vaccination: A conjoint analysis study Stockwell, Melissa S.
 2011
 29 Supplement 4 p. 4507-4511
5 p.
 artikel
170 The future of pneumococcal disease prevention Rodgers, Gail L.
 2011
 29 Supplement 4 p. C43-C48
nvt p.
 artikel
171 The global polio eradication initiative: Lessons learned and prospects for success Aylward, Bruce
 2011
 29 Supplement 4 p. D80-D85
nvt p.
 artikel
172 The immunogenicity and impact on nasopharyngeal carriage of fewer doses of conjugate pneumococcal vaccine immunization schedule Ota, Martin O.
 2011
 29 Supplement 4 p. 2999-3007
9 p.
 artikel
173 The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children Thanee, Chareeya
 2011
 29 Supplement 4 p. 5886-5891
6 p.
 artikel
174 The immunogenicity of pneumococcal polysaccharides in infants and children: A meta-regression Laferriere, Craig
 2011
 29 Supplement 4 p. 6838-6847
10 p.
 artikel
175 The impact of additional pertussis vaccine doses on disease incidence in children and infants Stein-Zamir, Chen
 2010
 29 Supplement 4 p. 207-211
5 p.
 artikel
176 The introduction of multi-copy CpG motifs into an antiviral DNA vaccine strongly up-regulates its immunogenicity in fish Martinez-Alonso, S.
 2011
 29 Supplement 4 p. 1289-1296
8 p.
 artikel
177 The PEDVAC trial: Preliminary data from the first therapeutic DNA vaccination in HIV-infected children Palma, Paolo
 2011
 29 Supplement 4 p. 6810-6816
7 p.
 artikel
178 The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep Maggioli, Gabriela
 2011
 29 Supplement 4 p. 9057-9063
7 p.
 artikel
179 Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4–5 years after a previous dose Halperin, Scott A.
 2011
 29 Supplement 4 p. 8459-8465
7 p.
 artikel
180 Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine Chen, Jie
 2011
 29 Supplement 4 p. 706-711
6 p.
 artikel
181 Tumor-specific peptide-based vaccines containing the conformationally biased, response-selective C5a agonists EP54 and EP67 protect against aggressive large B cell lymphoma in a syngeneic murine model Kollessery, Gayathri
 2011
 29 Supplement 4 p. 5904-5910
7 p.
 artikel
182 Two alternative inocula to reproduce bluetongue virus serotype 8 disease in calves Martinelle, Ludovic
 2011
 29 Supplement 4 p. 3600-3609
10 p.
 artikel
183 Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults Hatakeyama, Shuji
 2011
 29 Supplement 4 p. 9224-9228
5 p.
 artikel
184 Vaccination policies for health-care workers in acute health-care facilities in Europe Maltezou, Helena C.
 2011
 29 Supplement 4 p. 9557-9562
6 p.
 artikel
185 Vaccinia virus as a vaccine delivery system for marsupial wildlife Cross, Martin L.
 2011
 29 Supplement 4 p. 4537-4543
7 p.
 artikel
186 Voluntary reporting of employee influenza vaccination rates by acute care hospitals in Iowa: The impact of a four year provider-based statewide performance improvement project Helms, Charles
 2011
 29 Supplement 4 p. 3483-3488
6 p.
 artikel
187 Wide-range protection against avian reovirus conferred by vaccination with representatives of four defined genotypes Lublin, Avishai
 2011
 29 Supplement 4 p. 8683-8688
6 p.
 artikel
                             187 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland